Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 2/20 | 0.44 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.33 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.32 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | CTSG | P08311 | 1/20 | 0.31 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.31 |
| ▸ | CMA1 | P23946 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19169471 | 0.92 | DGAT1 (0.39) | DGAT1CYP4F2CYP4A11TSHRALDH1A1 | |
| SCHEMBL17679314 | 0.90 | ACLY (0.42) | DGAT1CYP4F2CYP4A11TSHRALDH1A1 | |
| SCHEMBL1798350 | 0.87 | ELANE (0.47) | DGAT1CYP4F2CYP4A11TSHRALDH1A1 | |
| SCHEMBL1555747 | 0.87 | DGAT1 (0.39) | DGAT1CYP4F2CYP4A11TSHRALDH1A1 | |
| SCHEMBL364781 | 0.87 | CYP4F2 (0.44) | DGAT1CYP4F2CYP4A11TSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL4316792 | 0.85 | DGAT1 (0.38) | DGAT1CYP4F2CYP4A11TSHRKCNN4 | |
| Ammonia Solution, Strong SCHEMBL28497724 | 0.85 | CYP4F2 (0.42) | DGAT1CYP4F2CYP4A11TSHRKCNN4 | |
| SCHEMBL17068149 | 0.85 | DGAT1 (0.38) | DGAT1CYP4F2CYP4A11TSHRKCNN4 | |
| SCHEMBL1661232 | 0.85 | DGAT1 (0.38) | DGAT1CYP4F2CYP4A11TSHRKCNN4 | |
| SCHEMBL12803851 | 0.85 | DGAT1 (0.38) | DGAT1CYP4F2CYP4A11TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019110355-A1 | BRANCHED ADIPIC ACID BASED ESTERS AS NOVEL BASE STOCKS AND LUBRICANTS | BASF SE (DE) | 2019-06-13 | — | — | WO | disclosed |
| US-20180127533-A1 | One Step Synthesis of Ultrahigh Molecular Weight Block Copolymers | CLEMSON UNIVERSITY RESEARCH FOUNDATION | 2018-05-10 | — | — | US | disclosed |
| EP-2516378-B1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | UNIV READING (GB) | 2014-01-22 | — | — | EP | disclosed |
| EP-2516378-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | The University of Reading (GB) | 2012-10-31 | — | — | EP | disclosed |
| EP-2516378-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | The University of Reading (GB) | 2012-10-31 | — | — | EP | disclosed |
| US-20120264935-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | THE UNIVERSITY OF READING (GB) | 2012-10-18 | — | — | US | disclosed |
| US-20120264935-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | THE UNIVERSITY OF READING (GB) | 2012-10-18 | — | — | US | disclosed |
| WO-2011077081-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | THE UNIVERSITY OF READING (GB) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011077081-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | THE UNIVERSITY OF READING (GB) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120264935-A1 | SYNTHESIS OF LIGANDS FOR USE IN ACTINIDE EXTRACTION | ENO1, DIAPH1, DBN1 | DGAT1 971/4885CYP4F2 2375/4885CYP4A11 3474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.